Axsome Therapeutics, Inc. (FRA:19X)

Axsome Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	325.27	315.35	386.19	200.84	86.47	183.88
Cash & Short-Term Investments	325.27	315.35	386.19	200.84	86.47	183.88
Cash Growth	-0.63%	-18.34%	92.29%	132.26%	-52.97%	-16.41%
Receivables	196.51	142	94.82	37.7	-	-
Inventory	23.77	15.73	15.14	4.32	-	-
Prepaid Expenses	19.79	11.98	8.12	2.78	0.05	0.15
Total Current Assets	565.34	485.06	504.26	245.64	86.52	184.02
Property, Plant & Equipment	22.26	5.97	7.62	1.14	0.94	1.79
Goodwill	12.04	12.04	12.04	10.31	-	-
Other Intangible Assets	42.13	46.89	53.29	59.66	-	-
Other Long-Term Assets	27.48	18.53	11.03	14.72	0.32	0.32
Total Assets	669.25	568.5	588.24	331.48	87.79	186.13
Accounts Payable	54.23	72	40.68	38.61	13.15	13.5
Accrued Expenses	223.14	145.61	90.5	51.63	9.3	8.71
Short-Term Debt	70	-	-	-	-	-
Current Portion of Leases	3.23	3.26	1.27	0.43	0.62	1.22
Current Income Taxes Payable	-	0.96	-	-	-	-
Other Current Liabilities	9.7	8.29	6.41	5.9	-	-
Total Current Liabilities	360.29	230.1	138.85	96.56	23.07	23.44
Long-Term Debt	117.64	180.71	178.07	94.26	49.09	48.32
Long-Term Leases	27.72	8.99	7.04	-	-	0.58
Other Long-Term Liabilities	89.87	91.68	73.3	31.1	-	-
Total Liabilities	595.52	511.48	397.26	221.92	72.15	72.34
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	1,351	1,180	1,027	705.89	424.83	392.59
Retained Earnings	-1,277	-1,123	-835.57	-596.33	-409.2	-278.8
Shareholders' Equity	73.73	57.02	190.98	109.56	15.63	113.79
Total Liabilities & Equity	669.25	568.5	588.24	331.48	87.79	186.13
Total Debt	218.6	192.96	186.37	94.68	49.71	50.12
Net Cash (Debt)	106.68	122.4	199.82	106.16	36.76	133.75
Net Cash Growth	-21.00%	-38.75%	88.23%	188.77%	-72.51%	-33.13%
Net Cash Per Share	2.17	2.55	4.40	2.61	0.98	3.59
Filing Date Shares Outstanding	50.41	48.77	47.37	43.52	38.48	37.41
Total Common Shares Outstanding	50.31	48.67	47.35	43.5	37.82	37.37
Working Capital	205.05	254.96	365.41	149.08	63.45	160.59
Book Value Per Share	1.47	1.17	4.03	2.52	0.41	3.04
Tangible Book Value	19.56	-1.92	125.65	39.59	15.63	113.79
Tangible Book Value Per Share	0.39	-0.04	2.65	0.91	0.41	3.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.